US Stock MarketDetailed Quotes

GRCE Grace Therapeutics

Watchlist

3.003
-0.197-6.17%

Trading Nov 1 11:56 ET

30.45MMarket Cap-2859P/E (TTM)

Grace Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Jun 30, 2024

(FY)Mar 31, 2024

(Q4)Mar 31, 2024

(Q3)Dec 31, 2023

(Q2)Sep 30, 2023

(Q1)Jun 30, 2023

(FY)Mar 31, 2023

(Q4)Mar 31, 2023

(Q3)Dec 31, 2022

(Q2)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

42.36%-3.6M

22.50%-12.33M

37.22%-2.09M

49.19%-1.89M

38.53%-2.11M

-15.00%-6.24M

7.67%-15.91M

-5.76%-3.33M

18.80%-3.72M

43.66%-3.44M

Net income from continuing operations

34.95%-2.62M

69.71%-12.85M

89.12%-3.17M

38.52%-2.39M

33.60%-3.27M

11.07%-4.02M

-332.11%-42.43M

-645.06%-29.09M

-2.94%-3.89M

-602.45%-4.93M

Operating gains losses

---1.4M

7,864.71%2.71M

1,379.17%1.07M

-643.48%-125K

----

100.61%34K

129.88%72K

102.78%23K

99.11%-41K

Depreciation and amortization

-85.71%1K

-91.13%11K

-87.50%1K

-90.00%1K

103.28%2K

-95.81%7K

--124K

--8K

--10K

---61K

Deferred tax

-150.52%-724K

80.80%-1.83M

89.98%-889K

24.09%-208K

-187.74%-446K

-19.42%-289K

-1,372.53%-9.54M

-1,268.98%-8.87M

---274K

---155K

Other non cash items

--1K

----

Change In working capital

144.42%900K

-807.18%-1.28M

99.43%704K

1,545.71%506K

-140.92%-464K

-59.40%-2.03M

106.50%181K

-65.79%353K

94.88%-35K

143.58%1.13M

-Change in receivables

1,031.43%326K

126.49%80K

797.06%237K

-234.07%-122K

--0

91.94%-35K

-1,577.78%-302K

89.03%-34K

-84.28%91K

119.74%75K

-Change in prepaid assets

35.92%-339K

337.50%315K

16.30%528K

-27.64%233K

-38.52%83K

36.95%-529K

118.95%72K

-59.72%454K

-2.72%322K

111.38%135K

-Change in payables and accrued expense

163.01%913K

-501.95%-1.65M

8.96%-61K

188.17%395K

-158.12%-537K

-72,550.00%-1.45M

117.21%411K

-131.16%-67K

71.88%-448K

189.19%924K

-Change in other current assets

--0

---23K

--0

---10K

---13K

--0

----

Cash from discontinued investing activities

Operating cash flow

42.37%-3.6M

22.50%-12.33M

37.22%-2.09M

49.17%-1.89M

38.56%-2.11M

-15.00%-6.24M

7.67%-15.91M

-5.76%-3.33M

18.80%-3.72M

43.66%-3.44M

Investing cash flow

Cash flow from continuing investing activities

-15K

-99.21%104K

31.17%6.55M

-31.05%-6.55M

214.58%110K

473.45%13.15M

45,281.82%4.99M

-997.85%-5M

-103.38%-96K

Net PPE purchase and sale

----

623.53%89K

-162.50%-21K

--0

----

---17K

---8K

--0

---2K

Net investment purchase and sale

---15K

-99.89%15K

31.38%6.57M

-31.05%-6.55M

--0

473.94%13.17M

45,354.55%5M

-997.85%-5M

-103.31%-94K

Cash from discontinued investing activities

Investing cash flow

---15K

-99.21%104K

31.17%6.55M

-31.05%-6.55M

214.58%110K

--0

473.45%13.15M

45,281.82%4.99M

-997.85%-5M

-103.38%-96K

Financing cash flow

Cash flow from continuing financing activities

2,320.72%7.36M

304K

109K

Net common stock issuance

----

2,313.82%7.34M

--0

----

--304K

--0

--109K

Proceeds from stock option exercised by employees

----

--21K

--0

----

--0

----

Cash from discontinued financing activities

Financing cash flow

----

2,320.72%7.36M

--0

----

--304K

--0

--109K

Net cash flow

Beginning cash position

-17.47%23.01M

-8.12%27.88M

-29.33%18.55M

-22.72%26.99M

-43.63%21.63M

-8.12%27.88M

-40.44%30.34M

-20.51%26.24M

-5.42%34.93M

-6.34%38.38M

Current changes in cash

42.13%-3.61M

-98.29%-4.87M

167.71%4.46M

3.18%-8.45M

256.33%5.36M

-177.74%-6.24M

88.17%-2.46M

153.16%1.67M

-116.61%-8.72M

-4.87%-3.43M

Effect of exchange rate changes

--0

108.00%2K

-118.18%-2K

-105.23%-8K

-106.96%-32K

-65.77%38K

96.79%-25K

End cash Position

-10.35%19.39M

-17.47%23.01M

-29.33%18.55M

-22.72%26.99M

-43.63%21.63M

-8.12%27.88M

-20.51%26.24M

-5.42%34.93M

Free cash flow

42.37%-3.6M

22.44%-12.36M

36.71%-2.11M

49.17%-1.89M

38.59%-2.11M

-14.85%-6.24M

7.57%-15.93M

-6.01%-3.33M

18.80%-3.72M

43.63%-3.44M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Jun 30, 2024	(FY)Mar 31, 2024	(Q4)Mar 31, 2024	(Q3)Dec 31, 2023	(Q2)Sep 30, 2023	(Q1)Jun 30, 2023	(FY)Mar 31, 2023	(Q4)Mar 31, 2023	(Q3)Dec 31, 2022	(Q2)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	42.36%-3.6M	22.50%-12.33M	37.22%-2.09M	49.19%-1.89M	38.53%-2.11M	-15.00%-6.24M	7.67%-15.91M	-5.76%-3.33M	18.80%-3.72M	43.66%-3.44M
Net income from continuing operations	34.95%-2.62M	69.71%-12.85M	89.12%-3.17M	38.52%-2.39M	33.60%-3.27M	11.07%-4.02M	-332.11%-42.43M	-645.06%-29.09M	-2.94%-3.89M	-602.45%-4.93M
Operating gains losses	---1.4M	7,864.71%2.71M	1,379.17%1.07M	-643.48%-125K	----	----	100.61%34K	129.88%72K	102.78%23K	99.11%-41K
Depreciation and amortization	-85.71%1K	-91.13%11K	-87.50%1K	-90.00%1K	103.28%2K	-95.81%7K	--124K	--8K	--10K	---61K
Deferred tax	-150.52%-724K	80.80%-1.83M	89.98%-889K	24.09%-208K	-187.74%-446K	-19.42%-289K	-1,372.53%-9.54M	-1,268.98%-8.87M	---274K	---155K
Other non cash items	--1K	----	----	----	----	----	----	----	----	----
Change In working capital	144.42%900K	-807.18%-1.28M	99.43%704K	1,545.71%506K	-140.92%-464K	-59.40%-2.03M	106.50%181K	-65.79%353K	94.88%-35K	143.58%1.13M
-Change in receivables	1,031.43%326K	126.49%80K	797.06%237K	-234.07%-122K	--0	91.94%-35K	-1,577.78%-302K	89.03%-34K	-84.28%91K	119.74%75K
-Change in prepaid assets	35.92%-339K	337.50%315K	16.30%528K	-27.64%233K	-38.52%83K	36.95%-529K	118.95%72K	-59.72%454K	-2.72%322K	111.38%135K
-Change in payables and accrued expense	163.01%913K	-501.95%-1.65M	8.96%-61K	188.17%395K	-158.12%-537K	-72,550.00%-1.45M	117.21%411K	-131.16%-67K	71.88%-448K	189.19%924K
-Change in other current assets	--0	---23K	--0	--0	---10K	---13K	--0	--0	--0	----
Cash from discontinued investing activities
Operating cash flow	42.37%-3.6M	22.50%-12.33M	37.22%-2.09M	49.17%-1.89M	38.56%-2.11M	-15.00%-6.24M	7.67%-15.91M	-5.76%-3.33M	18.80%-3.72M	43.66%-3.44M
Investing cash flow
Cash flow from continuing investing activities	-15K	-99.21%104K	31.17%6.55M	-31.05%-6.55M	214.58%110K	0	473.45%13.15M	45,281.82%4.99M	-997.85%-5M	-103.38%-96K
Net PPE purchase and sale	----	623.53%89K	-162.50%-21K	--0	----	----	---17K	---8K	--0	---2K
Net investment purchase and sale	---15K	-99.89%15K	31.38%6.57M	-31.05%-6.55M	--0	--0	473.94%13.17M	45,354.55%5M	-997.85%-5M	-103.31%-94K
Cash from discontinued investing activities
Investing cash flow	---15K	-99.21%104K	31.17%6.55M	-31.05%-6.55M	214.58%110K	--0	473.45%13.15M	45,281.82%4.99M	-997.85%-5M	-103.38%-96K
Financing cash flow
Cash flow from continuing financing activities		2,320.72%7.36M	0	0			304K	0	0	109K
Net common stock issuance	----	2,313.82%7.34M	--0	--0	----	----	--304K	--0	--0	--109K
Proceeds from stock option exercised by employees	----	--21K	--0	--0	----	----	--0	--0	----	----
Cash from discontinued financing activities
Financing cash flow	----	2,320.72%7.36M	--0	--0	----	----	--304K	--0	--0	--109K
Net cash flow
Beginning cash position	-17.47%23.01M	-8.12%27.88M	-29.33%18.55M	-22.72%26.99M	-43.63%21.63M	-8.12%27.88M	-40.44%30.34M	-20.51%26.24M	-5.42%34.93M	-6.34%38.38M
Current changes in cash	42.13%-3.61M	-98.29%-4.87M	167.71%4.46M	3.18%-8.45M	256.33%5.36M	-177.74%-6.24M	88.17%-2.46M	153.16%1.67M	-116.61%-8.72M	-4.87%-3.43M
Effect of exchange rate changes	--0	--0	--0	--0	108.00%2K	-118.18%-2K	-105.23%-8K	-106.96%-32K	-65.77%38K	96.79%-25K
End cash Position	-10.35%19.39M	-17.47%23.01M	-17.47%23.01M	-29.33%18.55M	-22.72%26.99M	-43.63%21.63M	-8.12%27.88M	-8.12%27.88M	-20.51%26.24M	-5.42%34.93M
Free cash flow	42.37%-3.6M	22.44%-12.36M	36.71%-2.11M	49.17%-1.89M	38.59%-2.11M	-14.85%-6.24M	7.57%-15.93M	-6.01%-3.33M	18.80%-3.72M	43.63%-3.44M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data